New B vitamin?
This article was originally published in The Tan Sheet
Executive Summary
Researchers Takaoki Kasahara, et al., Brain Science Institute, Saitama, Japan, suggest that pyrroloquinoline quinone (PQQ) "be classified as a new B vitamin, joining niacin/nicotinic acid (vitamin B3) and riboflavin." In a study published in April 24 Nature, mice were fed either diet supplemented with PQQ or standard diet; those not receiving PQQ grew at a slower rate, suffered from a reduced immune response, were not as successful at reproduction and had fragile skin. PQQ's status as vitamin, cofactor or vitamin-like substance could be determined within five years...
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.